An update on the pathology and clinical management of gouty arthritis. - Wikidata - wikimedia - TriplyDB

An update on the pathology and clinical management of gouty arthritis.

An update on the pathology and clinical management of gouty arthritis.

http://www.wikidata.org/entity/Q35643985

about

Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes.Effects of RuPeng15 Powder (RPP15) on Monosodium Urate Crystal-Induced Gouty Arthritis in Rats Therapeutic Effect of Total Saponins from Dioscorea nipponica Makino on Gouty Arthritis Based on the NF-κB Signal Pathway: An In vitro Study Serum uric acid levels and the risk of flares among gout patients in a US managed care setting.Gout: An old disease in new perspective - A review.Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.Trikatu, a herbal compound that suppresses monosodium urate crystal-induced inflammation in rats, an experimental model for acute gouty arthritis.Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.Gadolinium-enhanced MRI features of acute gouty arthritis on top of chronic gouty involvement in different joints.

P2860

Q34322559-54FC34B9-013A-445B-9149-4B922BB9F240 Q35495434-B068D9B7-E579-47F3-85F6-DD058F2B790A Q35843196-0DBC37E4-7021-4D7C-888B-A1ECE1DCDB05 Q37186522-4186E908-E75F-4BEF-BCD9-7F4D2CBAF691 Q39360995-BB66F767-37B8-4555-A1EA-90CC91D69D3B Q40106739-52AB2802-CD0D-448B-9E44-549921522F36 Q40600319-9D787EFA-FCE2-42CD-8DE1-F0251A9A3EFB Q43414960-40E4CC04-852E-415D-BD9F-4D13F5330326 Q46823946-8FFF77C3-C9D3-4011-9160-3131462E8F88 Q46831880-CF5DE761-1608-406F-841E-3B9B3FC122D4

P2860

An update on the pathology and clinical management of gouty arthritis.

http://www.wikidata.org/entity/Q35643985

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

An update on the pathology and clinical management of gouty arthritis.

@ast

An update on the pathology and clinical management of gouty arthritis.

@en

type

label

An update on the pathology and clinical management of gouty arthritis.

@ast

An update on the pathology and clinical management of gouty arthritis.

@en

prefLabel

An update on the pathology and clinical management of gouty arthritis.

@ast

An update on the pathology and clinical management of gouty arthritis.

@en

P1433

Q35643985-15E0CAD4-F1DE-41A8-A298-3932C216519A

P1476

Q35643985-BE5D7986-E3E4-43AB-A188-FD7B7189128F

P2093

Q35643985-91D7859A-A50E-483A-9E5C-B0B4E57F5787

P2860

Q35643985-03703169-A9DD-43E2-A087-F4C65C1D7349

Q35643985-08260002-E59B-4A4B-AAD7-9EC9097810B6

Q35643985-0CD2885C-FCE8-4895-9434-6B16A8183518

Q35643985-0DD06483-CB99-4168-8AF6-1CFCDF7FD004

Q35643985-11C7A3A6-5DD5-4999-8655-DA6DC52C079A

Q35643985-148FAF49-05E6-431E-8E54-910BE9A91150

Q35643985-15C58531-6C92-4FE3-A5AA-255C7B9A43B9

Q35643985-1B2DB107-7A7D-4AB5-A79E-D192E2B5FB0E

Q35643985-1D2B3F8B-A828-48AF-BA89-A92A10ADAD75

Q35643985-23425418-1316-4718-B4C3-59B5944A21C9

P304

Q35643985-80E0F9B3-C7FE-44C5-A177-3D47B5FE4066

P31

Q35643985-766D490C-0DC7-4F1C-9152-C028CCD67C73

Q35643985-D09AD541-1252-4A3E-BEC5-1F69314BF099

P356

Q35643985-67871734-41DD-4A8E-B8F4-74DD590EBCC6

P433

Q35643985-73E35B41-8650-434C-8D7B-2E10603965F5

P478

Q35643985-13DAB0A5-8C61-46F1-825D-60DBF723B485

P577

Q35643985-0A619118-7B58-42E1-91B4-45A398FE9CCF

Q35643985-A73DFAB7-59A1-429C-8DBB-61BCFA73E9FB

P5875

Q35643985-8048C510-BDB1-4DD2-842A-D59617F2FD74

P698

Q35643985-BF2E5FE9-BFD6-46D8-9BF9-EE59188A4D98

P921

Q35643985-9F85C543-E058-4588-A91E-5582B1157946

Q35643985-D68A9E52-0C1E-43F4-A5DA-3298890A128A

P932

Q35643985-A1BBFD55-131B-48DA-96E0-248D29DCB91F

P356

S10067-011-1877-0

P1433

Clinical Rheumatology

P1476

An update on the pathology and clinical management of gouty arthritis.

@en

P2093

Emilio B Gonzalez

http://www.w3.org/2001/XMLSchema#string

P2860

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

A pilot study of IL-1 inhibition by anakinra in acute gout

Pathogenesis of Gout

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Gout-associated uric acid crystals activate the NALP3 inflammasome

Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting

Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

Molecular identification of a danger signal that alerts the immune system to dying cells

P304

13-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-011-1877-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51784911

http://www.w3.org/2001/XMLSchema#string

P698

22069122

http://www.w3.org/2001/XMLSchema#string

P921

human musculoskeletal system

P932

3249158

http://www.w3.org/2001/XMLSchema#string